General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, and clinical trial regimes. This is not legal advice and does not create an attorney–client relationship. Instruct qualified PRC counsel before you act.
Life sciences & healthcare legal cluster: Hub · Dawn raid · VBP · Hospital AR · Exclusive agency · HGR · Trial injury · CRO/CDMO · Device liability · Labeling · SaMD · Patent linkage · License · FDA WL · MDR/IVDR · Internet hospital · Trade secrets · Pharma ads · Device distribution · Sources · Checklist
Who this is for MAHs, importers, and distributors chasing public or private hospital AR; finance and legal teams designing stop-supply and litigation gates.
Map the debt before you escalate
- Contract chain: hospital ↔ distributor ↔ MAH/importer—who is the actual debtor?
- Delivery evidence: acceptance notes, UDI/lot, temperature logs for cold chain.
- Tender / VBP overlay: supply obligations that limit stop-ship rights — VBP guide.
- Guarantee or joint-liability language from hospital groups or platform intermediaries.
- Set-off claims: quality disputes, returns, alleged overcharges.
Commercial levers (before lawsuit)
- Structured repayment schedules with default acceleration and security (deposit, third-party guarantee).
- Calibrated stop-supply: check tender breach and patient-safety optics first.
- Escalate through hospital finance committees with bilingual evidence packs—not only WeChat pressure.
- Distributor termination + inventory audit if the intermediary is the weak link — exclusive agency termination.
Litigation & arbitration posture
Choose forum from the contract (court vs CIETAC/local commission). Preserve assets early where dissipation risk is real. Damages usually track unpaid principal, interest/penalty clauses, and sometimes collection costs if contracted. Quality counterclaims require a parallel technical file—do not let unpaid invoices become uncontrolled product-liability stories (see device liability).
Public hospital special issues
- Budget and appropriation cycles that delay payment without denying debt.
- Multi-campus groups with unclear contracting entities.
- Compliance optics: aggressive collection messaging that looks like improper influence—align with anti-corruption playbook.
Evidence checklist
- Signed supply contracts and amendments; tender award docs.
- Delivery/acceptance; invoices/fapiao chain; reconciliation statements.
- Written payment promises; meeting minutes; partial payment history.
- Quality complaint files and CAPA if set-off is threatened.
Related
VBP & distributors · Device distribution · Hub
FAQ · 高频检索问题
医院拖欠药款能否直接停货？
Sometimes—but tender/VBP supply duties and patient-care optics may restrict stop-supply. Document legal basis and notice before acting.
告医院还是告经销商？
Follow the contract chain and acceptance evidence. Often both relationships need parallel strategy.
账期过长如何预防？
Credit limits, guarantees, milestone billing, and tender-aware stop-supply clauses beat post-default heroics.
